NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NTR shares have increased by 6.6% and is now trading at $34.12. View which stocks have been most impacted by Coronavirus.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 6 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) announced its quarterly earnings data on Wednesday, May, 6th. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.08. The company had revenue of $4.19 billion for the quarter, compared to analyst estimates of $3.44 billion. Nutrien had a return on equity of 4.66% and a net margin of 4.49%. The business's revenue for the quarter was up 12.6% on a year-over-year basis. During the same period last year, the business earned $0.20 earnings per share. View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Wednesday, May 6th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.45 per share on Friday, July 17th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 5.28%. The ex-dividend date is Monday, June 29th. View Nutrien's dividend history.

Nutrien updated its FY20 earnings guidance on Wednesday, May, 6th. The company provided EPS guidance of $1.50-2.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.00.

21 analysts have issued 12-month price objectives for Nutrien's shares. Their forecasts range from $36.00 to $70.00. On average, they expect Nutrien's stock price to reach $49.50 in the next year. This suggests a possible upside of 45.1% from the stock's current price. View analysts' price targets for Nutrien.

Media headlines about NTR stock have been trending extremely negative on Friday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nutrien earned a coverage optimism score of -4.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutNutrien.

Nutrien saw a decline in short interest in May. As of May 15th, there was short interest totaling 3,280,000 shares, a decline of 22.3% from the April 30th total of 4,220,000 shares. Based on an average daily volume of 2,200,000 shares, the short-interest ratio is presently 1.5 days. Currently, 0.6% of the company's shares are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), Eden Research (EDEN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA) and Kiwa Bio-Tech Products Group (KWBT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), Bank of America (BAC), Cimarex Energy (XEC), Johnson & Johnson (JNJ), Intel (INTC), AT&T (T), Exxon Mobil (XOM), Micron Technology (MU), Verizon Communications (VZ) and Pfizer (PFE).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of retail and institutional investors. Top institutional investors include First Eagle Investment Management LLC (3.99%), CIBC Asset Management Inc (1.42%), Mackenzie Financial Corp (1.29%), 1832 Asset Management L.P. (1.22%), Capital International Investors (1.19%) and The Manufacturers Life Insurance Company (1.08%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, 1832 Asset Management L.P., Capital Research Global Investors, Invesco Ltd., Schroder Investment Management Group, Capital International Investors, Alberta Investment Management Corp, and Morgan Stanley.

NTR stock was acquired by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , State Street Corp, AGF Investments Inc., 1832 Asset Management L.P., Canada Pension Plan Investment Board, Janus Henderson Group PLC, CIBC Asset Management Inc, and Connor Clark & Lunn Investment Management Ltd..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $34.12.

Nutrien has a market capitalization of $19.44 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]